Identification of (bio)markers in Dementia with Lewy Bodies.

Completed

• Conditions: Dementia with Lewy Bodies; Lewy body dementia; 10083624; 10012272

• Registration Number: NL-OMON44099
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 230

Inclusion Criteria

Patients with (prodromal) Dementia with Lewy Bodies or (prodromal) Parkinson's Disease Dementia (including patients without mild cognitive impairment).

Exclusion Criteria

Mini Mental State Examination lower than 20 out of 30 points.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The development of a study database and biobank for the identification of new<br /><br>diagnostic and prognostic (bio)markers of Dementia with Lewy Bodies.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To identify DNA and CSF proteome alterations in familial DLB that could be used<br /><br>as biomarkers of Dementia with Lewy Bodies.</p><br>